Powers attorneys Joella Roland and Jason Reddish joined SpendMend’s 340B Unscripted podcast for an in-depth discussion of legal and policy developments affecting 340B covered entities.
Joella and Jason are members of Powers’ Drug Pricing and 340B Program Practice, which advises healthcare providers and other stakeholders on the complex legal, regulatory, compliance, and policy issues surrounding the 340B Drug Pricing Program.
In “Ep 99 | 340B Developments & Policy Discussion,” Joella and Jason examine recent 340B manufacturer activity, including contract pharmacy restrictions and claims data submission requirements, and discuss how 340B covered entities and healthcare providers are responding to these evolving requirements.
They also discuss recent judicial rulings affecting Health Resources and Services Administration (HRSA) policy and 340B regulatory enforcement, including issues involving child site eligibility timing and the 340B GPO Prohibition. Looking ahead, Joella and Jason examine proposed Centers for Medicare & Medicaid Services (CMS) rules involving Medicare Part B billing and Medicare Part D 340B data collection and consider what these developments could mean for 340B covered entities.
About 340B Unscripted
Pharmacists and healthcare industry leaders Rob ‘Hoopi’ Nahoopii PharmD, MS, ACE and Greg Wilson PharmD, BCPS, ACE dive deeply into the complicated and contentious 340B Program as well as other pressing Pharmacy matters. Special guests and industry experts pop in frequently to add insights from all sides of the discussion. If you serve in the pharmacy sector, this podcast is a must-listen! 340B Unscripted is available on major podcast and streaming platforms, including Spotify, Apple Podcasts, iHeartRadio, Amazon Music, and other popular podcast platforms.